Cargando…
CD11c(+) MHCII(lo) GM-CSF-bone marrow-derived dendritic cells act as antigen donor cells and as antigen presenting cells in neoepitope-elicited tumor immunity against a mouse fibrosarcoma
Dendritic cells play a critical role in initiating T-cell responses. In spite of this recognition, they have not been used widely as adjuvants, nor is the mechanism of their adjuvanticity fully understood. Here, using a mutated neoepitope of a mouse fibrosarcoma as the antigen, and tumor rejection a...
Autores principales: | Ebrahimi-Nik, Hakimeh, Corwin, William L., Shcheglova, Tatiana, Das Mohapatra, Alok, Mandoiu, Ion I., Srivastava, Pramod K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6132860/ https://www.ncbi.nlm.nih.gov/pubmed/30030558 http://dx.doi.org/10.1007/s00262-018-2202-4 |
Ejemplares similares
-
Mass spectrometry–driven exploration reveals nuances of neoepitope-driven tumor rejection
por: Ebrahimi-Nik, Hakimeh, et al.
Publicado: (2019) -
Reversion analysis reveals the in vivo immunogenicity of a poorly MHC I-binding cancer neoepitope
por: Ebrahimi-Nik, Hakimeh, et al.
Publicado: (2021) -
An unbiased approach to defining bona fide cancer neoepitopes that elicit immune-mediated cancer rejection
por: Brennick, Cory A., et al.
Publicado: (2021) -
Characterization of splenic MRC1(hi)MHCII(lo) and MRC1(lo)MHCII(hi) cells from the monocyte/macrophage lineage of White Leghorn chickens
por: Yu, Keesun, et al.
Publicado: (2020) -
A universal MHCII technology platform to characterize antigen-specific CD4(+) T cells
por: Vyasamneni, Rohit, et al.
Publicado: (2023)